personalised medicine
R&D/ Views & Analysis/ Views and analysis
Herd immunity is nice – but what about me?
Catherine Longworth
antibody testing, COVID-19, immunity, personalised medicine
0 Comment
Digital/ Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
A roadmap for adopting New Science
George Underwood
Accenture, Innovation, personalised medicine, reimbursement
0 Comment
COSMIC database matches drugs to cancer mutations
Phil Taylor
cancer, digital, Oncology, personalised medicine, precision medicine, Sanger Institute, Wellcome
0 Comment
R&D/ Views & Analysis/ Views and analysis
Could personalised medicine change treatment for migraine?
Richard Staines
Curelator, migraine, migraine treatment, N1-Headache, personalised medicine
0 Comment
Oncology/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
Preparing for the next decade of innovation in immuno-oncology
mike.smith@pharmaphorum.com
Advanced Clinical, cancer, cancer immunotherapy, immuno-oncology, Oncology, personalised medicine
0 Comment
R&D/ Views & Analysis/ Views and analysis
Four predictions on the future of personalised medicine
mike.hammerton@pharmaphorum.com
cancer, personalised medicine
0 Comment
Oncology/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
The state of personalised medicine in 2019
mike.hammerton@pharmaphorum.com
cancer, personalised medicine
0 Comment
Debates & Insight/ Oncology/ Webinars/ Webinars in home page/ Webinars On demand
Cancer, genomics and personalised medicine: Modelling oncology’s future
louise.bellamy@pharmaphorum.com
cancer, clinical trials, genomics, personalised medicine, Repositive
0 Comment